AstraZeneca has probably the best antibiotic pipeline in the industry. It's also a business they no longer want to be in.
Their departure would follow on the heels of Pfizer exiting that segment, leaving GlaxoSmithKline and Merck.
Why? Well, pharmaceuticals in general in crisis. I have likened it to the US steel industry in the 1970s. Critics think if they are still making money, it must be okay and they can hammer on them indefinitely. But that isn't how business works. If government-controlled academia has to take over pharmaceutical development, we are doomed.
Credit: Life Sciences Foundation
Antibiotic resistance happens, there is no escaping it. To combat that, we need new antibiotics, plain and simple. But for regulatory bodies and anti-science activists, drug companies are open season for cultural sniping.
UK Prime Minister David Cameron is setting up a task force to come up with a policy for antibiotic resistance. Meanwhile, the company with the best products on the horizon is in the UK - and trying to jettison that business.
The solution seems simple: stop treating drug companies like they are the enemy. Development is horrifically expensive, they get a short window to sell it before it goes generic, and they are criticized for trying to make their money back. If anything goes wrong despite a hundred million dollars in tests, they are sued.
That's not a return on investment anyone wants to risk.
Can David Cameron Save AZ's Antibiotics? by David Shlaes
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Vitriolic Abuse Of Anita Sarkeesian: Why The Games Industry Needs Her
- Sam Ting On AMS Results: Dark Matter Might Be One Seminar Away
- Why Natural Gas, Including Fracking, Is Better For The Environment Than Wind And Solar
- Mysterious 1808 Eruption - The Real Cause Of The Coldest Decade Of The Last 500 Years
- BICEP2's vision wasn't that strong, Planck says their window was too dusty.
- Triclosan In Utero May Disrupt Growth Of Boys, But BPA Doesn't
- Graphene Sensor Tracks Down Cancer Biomarkers
- "The potential for a discovery is there Anon. It's in the high-energy data and the antiproton data..."
- "It's amazing to see the PR machine that Ting has put together at work. Not only do we have to wait..."
- ":) Actually amphetamine salts were not sustainable as an ADHD solution for me. They actually did..."
- "Hi Hontas. This caught my eye: That said, it may be that there simply is no strong signal of inflation..."
- "1.) Fundamentally one can never prove any theory. That's what makes a theory different from..."
- Patients accept false-positives to achieve diagnostic sensitivity
- Mefloquine fails to replace SP for malaria prevention during pregnancy
- The mechanics of tissue growth
- Microplastic pollution discovered in St. Lawrence River sediments
- Insects' fear limits boost from climate change, Dartmouth study shows